MedTrace Logo

Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women

NCT07408115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2026-02-12

No results posted yet for this study

Summary

The goal of this study is to evaluate the efficacy of a neurokinin 1,3 antagonist on improving vasomotor symptoms (VMS) and overall menopause symptoms in women between the ages of 40-70. The primary research question is whether taking the study product daily for 4 weeks with an optional 8 week extension, significantly reduces the severity and frequency of menopause-related symptoms.

Conditions

  • Hot Flashes
  • Hot Flash
  • Hot Flushes, Menopause, Postmenopause
  • Hot Flushes and/or Sweats
  • Hot Flushes
  • Night Sweats
  • Vasomotor Symptoms
  • Vasomotor Symptoms (VMS)
  • Vasomotor Symptoms Associated With Menopause

Interventions

DIETARY_SUPPLEMENT

JDS-HF3.0

Active Supplement JDS-HF3.0

Sponsors & Collaborators

  • Bonafide Health

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-24
Primary Completion
2024-12-18
Completion
2024-12-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07408115 on ClinicalTrials.gov